Akashi Therapeutics

0 followers

‌

Akashi Therapeutics is a clinical stage biotechnology company developing a portfolio of products for Duchenne muscular dystrophy and other rare diseases.

Industries

Headquarters

Employees

Links

Org chart

Marc B. Blaustein

CEO

Marc B. Blaustein

Collapse

Ernest D. Bush

Chief Scientific Officer

Diana Escolar

Chief Medical Officer

Teams

Scientific Advisory Team

6 members

Leadership Team

3 members

Similar companies

Emergent BioSolutions

4 followers

Owkin

4 followers

Thermo Fisher Scientific

145 followers

Gilead Sciences

121 followers

Biogen

108 followers

Regeneron

89 followers

Agilent Technologies

61 followers

Vertex Pharmaceuticals

50 followers

Alexion Pharmaceuticals

33 followers

GRAIL

27 followers

BeiGene

19 followers

Discover companies

��������